Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective
The treatment of chronic pain, therapeutic opioid use and abuse, and the nonmedical use of prescription drugs have been topics of intense focus and debate. After the liberalization of laws governing opioid prescribing for the treatment of chronic non-cancer pain by state medical boards in the late 1...
Gespeichert in:
Veröffentlicht in: | Pain physician 2010-09, Vol.13 (5), p.401-435 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 435 |
---|---|
container_issue | 5 |
container_start_page | 401 |
container_title | Pain physician |
container_volume | 13 |
creator | Manchikanti, Laxmaiah Fellows, Bert Ailinani, Hary Pampati, Vidyasagar |
description | The treatment of chronic pain, therapeutic opioid use and abuse, and the nonmedical use of prescription drugs have been topics of intense focus and debate. After the liberalization of laws governing opioid prescribing for the treatment of chronic non-cancer pain by state medical boards in the late 1990s, and with the introduction of new pain management standards implemented by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) in 2000, opioids, in general, and the most potent forms of opioids including Schedule II drugs, in particular, have dramatically increased. Despite the escalating use and abuse of therapeutic opioids, nearly 15 to 20 years later the scientific evidence for the effectiveness of opioids for chronic non-cancer pain remains unclear. Concerns continue regarding efficacy; problematic physiologic effects such as hyperalgesia, hypogonadism and sexual dysfunction; and adverse side effects - especially the potential for misuse and abuse - and the increase in opioid-related deaths. Americans, constituting only 4.6% of the world's population, have been consuming 80% of the global opioid supply, and 99% of the global hydrocodone supply, as well as two-thirds of the world's illegal drugs. Retail sales of commonly used opioid medications (including methadone, oxycodone, fentanyl base, hydromorphone, hydrocodone, morphine, meperidine, and codeine) have increased from a total of 50.7 million grams in 1997 to 126.5 million grams in 2007. This is an overall increase of 149% with increases ranging from 222% for morphine, 280% for hydrocodone, 319% for hydromorphone, 525% for fentanyl base, 866% for oxycodone, to 1,293% for methadone. Average sales of opioids per person have increased from 74 milligrams in 1997 to 369 milligrams in 2007, a 402% increase. Surveys of nonprescription drug abuse, emergency department visits for prescription controlled drugs, unintentional deaths due to prescription controlled substances, therapeutic use of opioids, and opioid abuse have been steadily rising. This manuscript provides an updated 10-year perspective on therapeutic use, abuse, and non-medical use of opioids and their consequences. |
doi_str_mv | 10.36076/ppj.2010/13/401 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_755199148</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>755199148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-bfd5efea77566ca9b78eb19b78159333407f9b71a907390d58fdca5e678658cb3</originalsourceid><addsrcrecordid>eNpdkL1PwzAUxC0EoqWwMyFLDCyk9YtjJ2ZDFV9SEUuZLcd5EanaONgJUv97XFoYmE5P7-50-hFyCWzKJcvlrOtW05QBmwGfZQyOyDgFwRKATB2TMQjOEw5CjchZCCvGuFSKn5JRygqhOKRj8rr8QG86HPrG0iHgLTXlXtqKtq7dYNVYs969qKup6xrXVOGOGtpjm2zReNqhDx3avvnCc3JSm3XAi4NOyPvjw3L-nCzenl7m94vEcgF9UtaVwBpNngsprVFlXmAJO4lbOecZy-t4gVEs54pVoqgrawTKvJCisCWfkJt9b-fd54Ch15smWFyvTYtuCDoXApSCrIjO63_OlRt8G8fpVAqhVKZARhfbu6x3IXisdeebjfFbDUz_kNaRtN6R1sB1JB0jV4fioYyQ_gK_aPk36EJ4mw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2655994916</pqid></control><display><type>article</type><title>Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Manchikanti, Laxmaiah ; Fellows, Bert ; Ailinani, Hary ; Pampati, Vidyasagar</creator><creatorcontrib>Manchikanti, Laxmaiah ; Fellows, Bert ; Ailinani, Hary ; Pampati, Vidyasagar</creatorcontrib><description>The treatment of chronic pain, therapeutic opioid use and abuse, and the nonmedical use of prescription drugs have been topics of intense focus and debate. After the liberalization of laws governing opioid prescribing for the treatment of chronic non-cancer pain by state medical boards in the late 1990s, and with the introduction of new pain management standards implemented by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) in 2000, opioids, in general, and the most potent forms of opioids including Schedule II drugs, in particular, have dramatically increased. Despite the escalating use and abuse of therapeutic opioids, nearly 15 to 20 years later the scientific evidence for the effectiveness of opioids for chronic non-cancer pain remains unclear. Concerns continue regarding efficacy; problematic physiologic effects such as hyperalgesia, hypogonadism and sexual dysfunction; and adverse side effects - especially the potential for misuse and abuse - and the increase in opioid-related deaths. Americans, constituting only 4.6% of the world's population, have been consuming 80% of the global opioid supply, and 99% of the global hydrocodone supply, as well as two-thirds of the world's illegal drugs. Retail sales of commonly used opioid medications (including methadone, oxycodone, fentanyl base, hydromorphone, hydrocodone, morphine, meperidine, and codeine) have increased from a total of 50.7 million grams in 1997 to 126.5 million grams in 2007. This is an overall increase of 149% with increases ranging from 222% for morphine, 280% for hydrocodone, 319% for hydromorphone, 525% for fentanyl base, 866% for oxycodone, to 1,293% for methadone. Average sales of opioids per person have increased from 74 milligrams in 1997 to 369 milligrams in 2007, a 402% increase. Surveys of nonprescription drug abuse, emergency department visits for prescription controlled drugs, unintentional deaths due to prescription controlled substances, therapeutic use of opioids, and opioid abuse have been steadily rising. This manuscript provides an updated 10-year perspective on therapeutic use, abuse, and non-medical use of opioids and their consequences. </description><identifier>ISSN: 1533-3159</identifier><identifier>EISSN: 2150-1149</identifier><identifier>DOI: 10.36076/ppj.2010/13/401</identifier><identifier>PMID: 20859312</identifier><language>eng</language><publisher>United States: American Society of Interventional Pain Physician</publisher><subject>Analgesics, Opioid ; Chronic Disease ; Drug Prescriptions - statistics & numerical data ; Fentanyl ; Humans ; Morphine ; Narcotics ; Pain - drug therapy ; Prescription drugs ; Substance-Related Disorders - epidemiology ; United States - epidemiology</subject><ispartof>Pain physician, 2010-09, Vol.13 (5), p.401-435</ispartof><rights>2010. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c351t-bfd5efea77566ca9b78eb19b78159333407f9b71a907390d58fdca5e678658cb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20859312$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Manchikanti, Laxmaiah</creatorcontrib><creatorcontrib>Fellows, Bert</creatorcontrib><creatorcontrib>Ailinani, Hary</creatorcontrib><creatorcontrib>Pampati, Vidyasagar</creatorcontrib><title>Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective</title><title>Pain physician</title><addtitle>Pain Physician</addtitle><description>The treatment of chronic pain, therapeutic opioid use and abuse, and the nonmedical use of prescription drugs have been topics of intense focus and debate. After the liberalization of laws governing opioid prescribing for the treatment of chronic non-cancer pain by state medical boards in the late 1990s, and with the introduction of new pain management standards implemented by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) in 2000, opioids, in general, and the most potent forms of opioids including Schedule II drugs, in particular, have dramatically increased. Despite the escalating use and abuse of therapeutic opioids, nearly 15 to 20 years later the scientific evidence for the effectiveness of opioids for chronic non-cancer pain remains unclear. Concerns continue regarding efficacy; problematic physiologic effects such as hyperalgesia, hypogonadism and sexual dysfunction; and adverse side effects - especially the potential for misuse and abuse - and the increase in opioid-related deaths. Americans, constituting only 4.6% of the world's population, have been consuming 80% of the global opioid supply, and 99% of the global hydrocodone supply, as well as two-thirds of the world's illegal drugs. Retail sales of commonly used opioid medications (including methadone, oxycodone, fentanyl base, hydromorphone, hydrocodone, morphine, meperidine, and codeine) have increased from a total of 50.7 million grams in 1997 to 126.5 million grams in 2007. This is an overall increase of 149% with increases ranging from 222% for morphine, 280% for hydrocodone, 319% for hydromorphone, 525% for fentanyl base, 866% for oxycodone, to 1,293% for methadone. Average sales of opioids per person have increased from 74 milligrams in 1997 to 369 milligrams in 2007, a 402% increase. Surveys of nonprescription drug abuse, emergency department visits for prescription controlled drugs, unintentional deaths due to prescription controlled substances, therapeutic use of opioids, and opioid abuse have been steadily rising. This manuscript provides an updated 10-year perspective on therapeutic use, abuse, and non-medical use of opioids and their consequences. </description><subject>Analgesics, Opioid</subject><subject>Chronic Disease</subject><subject>Drug Prescriptions - statistics & numerical data</subject><subject>Fentanyl</subject><subject>Humans</subject><subject>Morphine</subject><subject>Narcotics</subject><subject>Pain - drug therapy</subject><subject>Prescription drugs</subject><subject>Substance-Related Disorders - epidemiology</subject><subject>United States - epidemiology</subject><issn>1533-3159</issn><issn>2150-1149</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkL1PwzAUxC0EoqWwMyFLDCyk9YtjJ2ZDFV9SEUuZLcd5EanaONgJUv97XFoYmE5P7-50-hFyCWzKJcvlrOtW05QBmwGfZQyOyDgFwRKATB2TMQjOEw5CjchZCCvGuFSKn5JRygqhOKRj8rr8QG86HPrG0iHgLTXlXtqKtq7dYNVYs969qKup6xrXVOGOGtpjm2zReNqhDx3avvnCc3JSm3XAi4NOyPvjw3L-nCzenl7m94vEcgF9UtaVwBpNngsprVFlXmAJO4lbOecZy-t4gVEs54pVoqgrawTKvJCisCWfkJt9b-fd54Ch15smWFyvTYtuCDoXApSCrIjO63_OlRt8G8fpVAqhVKZARhfbu6x3IXisdeebjfFbDUz_kNaRtN6R1sB1JB0jV4fioYyQ_gK_aPk36EJ4mw</recordid><startdate>20100901</startdate><enddate>20100901</enddate><creator>Manchikanti, Laxmaiah</creator><creator>Fellows, Bert</creator><creator>Ailinani, Hary</creator><creator>Pampati, Vidyasagar</creator><general>American Society of Interventional Pain Physician</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20100901</creationdate><title>Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective</title><author>Manchikanti, Laxmaiah ; Fellows, Bert ; Ailinani, Hary ; Pampati, Vidyasagar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-bfd5efea77566ca9b78eb19b78159333407f9b71a907390d58fdca5e678658cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Analgesics, Opioid</topic><topic>Chronic Disease</topic><topic>Drug Prescriptions - statistics & numerical data</topic><topic>Fentanyl</topic><topic>Humans</topic><topic>Morphine</topic><topic>Narcotics</topic><topic>Pain - drug therapy</topic><topic>Prescription drugs</topic><topic>Substance-Related Disorders - epidemiology</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manchikanti, Laxmaiah</creatorcontrib><creatorcontrib>Fellows, Bert</creatorcontrib><creatorcontrib>Ailinani, Hary</creatorcontrib><creatorcontrib>Pampati, Vidyasagar</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pain physician</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manchikanti, Laxmaiah</au><au>Fellows, Bert</au><au>Ailinani, Hary</au><au>Pampati, Vidyasagar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective</atitle><jtitle>Pain physician</jtitle><addtitle>Pain Physician</addtitle><date>2010-09-01</date><risdate>2010</risdate><volume>13</volume><issue>5</issue><spage>401</spage><epage>435</epage><pages>401-435</pages><issn>1533-3159</issn><eissn>2150-1149</eissn><abstract>The treatment of chronic pain, therapeutic opioid use and abuse, and the nonmedical use of prescription drugs have been topics of intense focus and debate. After the liberalization of laws governing opioid prescribing for the treatment of chronic non-cancer pain by state medical boards in the late 1990s, and with the introduction of new pain management standards implemented by the Joint Commission on Accreditation of Healthcare Organizations (JCAHO) in 2000, opioids, in general, and the most potent forms of opioids including Schedule II drugs, in particular, have dramatically increased. Despite the escalating use and abuse of therapeutic opioids, nearly 15 to 20 years later the scientific evidence for the effectiveness of opioids for chronic non-cancer pain remains unclear. Concerns continue regarding efficacy; problematic physiologic effects such as hyperalgesia, hypogonadism and sexual dysfunction; and adverse side effects - especially the potential for misuse and abuse - and the increase in opioid-related deaths. Americans, constituting only 4.6% of the world's population, have been consuming 80% of the global opioid supply, and 99% of the global hydrocodone supply, as well as two-thirds of the world's illegal drugs. Retail sales of commonly used opioid medications (including methadone, oxycodone, fentanyl base, hydromorphone, hydrocodone, morphine, meperidine, and codeine) have increased from a total of 50.7 million grams in 1997 to 126.5 million grams in 2007. This is an overall increase of 149% with increases ranging from 222% for morphine, 280% for hydrocodone, 319% for hydromorphone, 525% for fentanyl base, 866% for oxycodone, to 1,293% for methadone. Average sales of opioids per person have increased from 74 milligrams in 1997 to 369 milligrams in 2007, a 402% increase. Surveys of nonprescription drug abuse, emergency department visits for prescription controlled drugs, unintentional deaths due to prescription controlled substances, therapeutic use of opioids, and opioid abuse have been steadily rising. This manuscript provides an updated 10-year perspective on therapeutic use, abuse, and non-medical use of opioids and their consequences. </abstract><cop>United States</cop><pub>American Society of Interventional Pain Physician</pub><pmid>20859312</pmid><doi>10.36076/ppj.2010/13/401</doi><tpages>35</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1533-3159 |
ispartof | Pain physician, 2010-09, Vol.13 (5), p.401-435 |
issn | 1533-3159 2150-1149 |
language | eng |
recordid | cdi_proquest_miscellaneous_755199148 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Analgesics, Opioid Chronic Disease Drug Prescriptions - statistics & numerical data Fentanyl Humans Morphine Narcotics Pain - drug therapy Prescription drugs Substance-Related Disorders - epidemiology United States - epidemiology |
title | Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T05%3A26%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20use,%20abuse,%20and%20nonmedical%20use%20of%20opioids:%20a%20ten-year%20perspective&rft.jtitle=Pain%20physician&rft.au=Manchikanti,%20Laxmaiah&rft.date=2010-09-01&rft.volume=13&rft.issue=5&rft.spage=401&rft.epage=435&rft.pages=401-435&rft.issn=1533-3159&rft.eissn=2150-1149&rft_id=info:doi/10.36076/ppj.2010/13/401&rft_dat=%3Cproquest_cross%3E755199148%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2655994916&rft_id=info:pmid/20859312&rfr_iscdi=true |